Nifty 17176.7 (1.56%)
Sensex 57633.65 (1.56%)
Nifty Bank 36618.4 (2.47%)
Nifty IT 35272.3 (1.13%)
Nifty Financial Services 17979.35 (2.17%)
Adani Ports 744.70 (2.94%)
Asian Paints 3030.35 (-0.26%)
Axis Bank 687.00 (3.60%)
B P C L 387.80 (1.13%)
Bajaj Auto 3286.45 (1.13%)
Bajaj Finance 7103.15 (2.18%)
Bajaj Finserv 17109.00 (1.28%)
Bharti Airtel 698.85 (0.18%)
Britannia Inds. 3474.20 (-0.63%)
Cipla 889.25 (-0.64%)
Coal India 150.65 (1.41%)
Divis Lab. 4624.80 (-0.47%)
Dr Reddys Labs 4520.70 (0.49%)
Eicher Motors 2471.80 (1.13%)
Grasim Inds 1685.55 (1.49%)
H D F C 2817.50 (1.76%)
HCL Technologies 1149.65 (1.15%)
HDFC Bank 1525.70 (1.46%)
HDFC Life Insur. 694.40 (1.49%)
Hero Motocorp 2461.80 (1.73%)
Hind. Unilever 2321.60 (0.65%)
Hindalco Inds. 442.50 (5.02%)
I O C L 120.60 (-0.29%)
ICICI Bank 734.65 (3.54%)
IndusInd Bank 926.65 (1.20%)
Infosys 1711.65 (0.96%)
ITC 220.65 (1.26%)
JSW Steel 660.65 (2.77%)
Kotak Mah. Bank 1937.15 (2.76%)
Larsen & Toubro 1798.10 (0.87%)
M & M 825.95 (0.46%)
Maruti Suzuki 7186.60 (2.04%)
Nestle India 19254.90 (1.25%)
NTPC 125.35 (0.80%)
O N G C 145.90 (1.78%)
Power Grid Corpn 205.80 (1.88%)
Reliance Industr 2381.85 (0.81%)
SBI Life Insuran 1159.15 (0.93%)
Shree Cement 25800.00 (0.73%)
St Bk of India 476.70 (2.45%)
Sun Pharma.Inds. 743.70 (0.89%)
Tata Consumer 760.70 (1.75%)
Tata Motors 481.80 (3.13%)
Tata Steel 1148.80 (3.61%)
TCS 3584.50 (1.36%)
Tech Mahindra 1576.65 (1.60%)
Titan Company 2380.55 (2.38%)
UltraTech Cem. 7299.40 (1.18%)
UPL 726.95 (1.45%)
Wipro 632.40 (1.27%)
IPO
27/07/2021

Macleod Pharma is one of the largest non-listed pharma plays in India. Macleod Pharma was floated by Dr. Rajendra Agarwal in 1986 to manufacture anti-tuberculosis drugs in India. The big news is that Macleod Pharma may be considering an IPO shortly, although they are yet to file the DRHP with SEBI. The IPO of Macleod Pharma was already doing rounds after the rip-roaring success of the Gland Pharma IPO last year.

It is being estimated that in terms of size, the Macleod Pharma IPO could be next only to Gland Pharma, which had raised Rs.6,480 crore through its IPO last year. In the last couple of years, pharma IPOs like Laurus Labs, Gland Pharma and Eris Life Sciences have done phenomenally well post listing. COVID-19 and the sudden rush for APIs and specialized generics is leading to a positive re-rating of pharma companies. Clearly, Macleod is planning its IPO to be in the right place at the right time.

Macleod Pharma has a rich 35 year legacy with strong focus on anti-tubercular, Anti-malarial, anti-bacterial, anti-retroviral and anti-diabetic medicines. Currently, Macleod has 14 manufacturing facilities for finished dosage and 2 facilities for manufacturing APIs. Macleod is a vertically integrated pharma company manufacturing close to 25 billion units of finished dosages annually. These include tablets, capsules, liquids, orals, inhalers, dry powders etc.

Macleod reaches out to over 150,000 doctors in India. Some of its popular brands in the market include Omnacortil, Lulimac, Budetrol, Defcort, Geminor, Vildamac, Olmesar, Nexovas, Thyrox, Tenlimac, Enzomac, Macfolate, Meromac, Tazomac, Montemac and Rebagen.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

Start Investing Now!

Open Free Demat Account in 5 mins

 
 
There is some issue, try later